News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kala Pharmaceuticals Receives Cystic Fibrosis Foundation Grant


2/5/2013 10:46:32 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today that it has been awarded a grant from the Cystic Fibrosis Foundation to demonstrate that Kala’s Mucosal-Penetrating Products (MPPs) also penetrate bacterial biofilms. Bacteria biofilms attach to respiratory surfaces and aggregate in a matrix that prevents antibiotics from effectively treating the chronic Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients that is linked to morbidity and mortality.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES